Skip to main content
SpringerLink
Log in

Hormonal Supplements Legal and Illegal

  • Chapter
Essentials of Sports Nutrition and Supplements

  • 10k Accesses

Abstract

Numerous hormones and hormone supplements are used by athletes in the hope of improving performance. Often, the marketing claims and gym lore regarding the utility of a given supplement do not agree with empirically obtained evidence. It is incumbent upon those who work with athletes to maintain a solid knowledge base regarding the science of hormone supplementation, as well as cultivate a process of critically appraising the current literature regarding hormone supplements. Indeed, it is likely that the science of hormonal manipulation will continue to evolve, and the rules and records will change to reflect modem athletes and their drive to succeed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Anti-Doping Agency. A Brief History of Anti-Doping. Montreal: WADA. Available at: www.wada-ama.org/en/dynamic.ch2?pageCategory _id = 20. Accessed June 30, 2005.

  2. Greenspan FS, Gardner DG. Basic & Clinical Endocrinology. 7th ed. New York: McGraw-Hill Medical; 2003.

    Google Scholar 

  3. Thiblin I, Peters son A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol 2005;19(1):27-44.

    CAS  Google Scholar 

  4. Gooren LJ, Bunck MC. Androgen replacement therapy: present and future. Drugs 2004;64(17):1861-1891.

    Article  CAS  Google Scholar 

  5. Black BE, Paschal BM. Intranuclear organization and function of the androgen receptor. Trends Endocrinol Metab 2004;15(9):411-417.

    Article  CAS  Google Scholar 

  6. Giammanco M, Tabacchi G, Giammanco S, Di Majo D, La Guardia M. Testosterone and aggressiveness. Med Sci Monit 2005;11(4):RA136-145.

    CAS  Google Scholar 

  7. Danhaive PA, Rousseau GG. Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. J Steroid Biochem 1986;24(2):481-487.

    Article  CAS  Google Scholar 

  8. Spence J. Effects of anabolic-androgenic steroids on muscular strength: a meta-analysis. Med Sci Sport Exerc 1999;31(5):Suppl abstract 2071.

    Google Scholar 

  9. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335(1):1-7.

    Article  CAS  Google Scholar 

  10. Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition, and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport 1999;2:341-355.

    Article  CAS  Google Scholar 

  11. Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7(3):271-277.

    Article  CAS  Google Scholar 

  12. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005;90(2):678-688.

    Article  CAS  Google Scholar 

  13. Bhasin S, Taylor WE, Singh R, et al. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci 2003;58(12):M1103-1110.

    Article  Google Scholar 

  14. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 2004;89(10):5245-5255.

    Article  CAS  Google Scholar 

  15. Parssinen M, Kujala U, Vartiainen E, Sarna S, Seppala T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 2000;21(3):225-227.

    Article  CAS  Google Scholar 

  16. Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000;45:16-23.

    CAS  Google Scholar 

  17. Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med 2004;38(3):253-259.

    Article  CAS  Google Scholar 

  18. Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med 2004;32(2):534-542.

    Article  Google Scholar 

  19. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34(8):513-554.

    Article  Google Scholar 

  20. Rich JD, Foisie CK, Towe CW, Dickinson BP, McKenzie M, Salas CM. Needle exchange program participation by anabolic steroid injectors, United States 1998. Drug Alcohol Depend 1999;56(2):157-160.

    Article  CAS  Google Scholar 

  21. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997;82(10):3493-3497.

    Article  CAS  Google Scholar 

  22. Broeder CE, Quindry T, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med 2000;160(20):3093-3104.

    Article  CAS  Google Scholar 

  23. Brown GA, Martini ER, Roberts BS, Vukovich MD, King DS. Acute hormonal response to sublingual androstenediol intake in young men. J Appl Physiol 2002;92:142-146.

    CAS  Google Scholar 

  24. Brown GA, Vukovich MD, Sharp RL, Reifenrath TA, Parsons KA, King DS. Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J Appl Physiol 1999;87:2274-2283.

    CAS  Google Scholar 

  25. Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men 2. J Gerontol A Biol Sci Med Sci 1997;52: M1-M7.

    Article  CAS  Google Scholar 

  26. Leder BZ, Longcope C, Catlin DH, Ahrens B, Schoenfeld DA, Finkelstein JS. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 2000;283(6):779-782.

    Article  CAS  Google Scholar 

  27. Kieman AT, Bassindale T, Cowan DA, Dale S, Hutt AT, Leeds AR. Effect of androstenedione ingestion on plasma testosterone in young women: a dietary supplement with potential health risks. Clin Chern 2003;49(1):167-169.

    Google Scholar 

  28. Ziegenfuss TN, Berardi JM, Lowery LM. Effects of prohormone supplementation in humans: a review. Can J Appl Physiol 2002;27(6):628-646.

    Article  CAS  Google Scholar 

  29. Kurata K, Takebayashi M, Morinobu S, Yamawaki S. beta-Estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-Daspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms. J Pharmacol Exp Ther 2004;311(1):237-245.

    Article  CAS  Google Scholar 

  30. MacLusky NT, Hajszan T, Leranth e. Effects of dehydroepiandrosterone and flutamide on hippocampal CAI spine synapse density in male and female rats: implications for the role of androgens in maintenance of hippocampal structure. Endocrinology 2004;145(9):4154-4161.

    CAS  Google Scholar 

  31. Celebi F, Yilmaz I, Aksoy H, Gumus M, Taysi S, Oren D. Dehydroepiandrosterone prevents oxidative injury in obstructive jaundice in rats. J Int Med Res 2004;32(4):400-405.

    CAS  Google Scholar 

  32. Bassett IH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003;213(1):1-11.

    Article  CAS  Google Scholar 

  33. Krotkiewski M. Thyroid hormones in the pathogenesis and treatment of obesity. Eur J Pharmacol 2002;44012-3):85-98.

    Article  CAS  Google Scholar 

  34. Clement K, Viguerie N, Diehn M, et al. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 2002;12(2):281-291.

    Article  CAS  Google Scholar 

  35. Hudecova S, Vadaszova A, Soukup T, Krizanova O. Effect of thyroid hormones on the gene expression of calcium transport systems in rat muscles. Life Sci 2004;75(8):923-931.

    Article  CAS  Google Scholar 

  36. Ralph CT. Finding and treating the cause of hyperthyroidism. JAAPA 2004; 1712):20, 23-26, 29, 30.

    Google Scholar 

  37. Rogol AD. Gender and hormonal regulation of growth. J Pediatr Endocrinol Metab 2004; 17(Suppl 4):1259- 1265.

    CAS  Google Scholar 

  38. Rosenfeld RG. The IGF system: new developments relevant to pediatric practice. Endocr Dev 2005;9:1-10.

    Article  CAS  Google Scholar 

  39. Svensson T, Johannson G. Long-term efficacy and safety of somatropin for adult growth hormone deficiency. Treat Endocrinol 2003;2(2):109-120.

    Article  CAS  Google Scholar 

  40. Arosio M, Ronchi CL, Epaminonda P, di Lembo S, Adda G. New therapeutic options for acromegaly. Minerva Endocrinol 2004;29(4):225-239.

    CAS  Google Scholar 

  41. Gagliardino JJ. Physiological endocrine control of energy homeostasis and postprandial blood glucose levels. Eur Rev Med Pharmacol Sci 2005;9(2):75-92.

    Google Scholar 

  42. Plum L, Schubert M, Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 2005;16(2):59-65.

    Article  CAS  Google Scholar 

  43. Santeusanio F, Di Loreto C, Lucidi P, et al. Diabetes and exercise. J Endocrinol Invest 2003;26(9):937-940.

    CAS  Google Scholar 

  44. Evans PT, Lynch RM. Insulin as a drug of abuse in body building. Br J Sports Med 2003;37:356-357.

    Article  CAS  Google Scholar 

  45. Rich JD, Dickinson BP, Merriman NA, Thule PM. Insulin use by bodybuilders. JAMA 1998;279(20):1613.

    Article  CAS  Google Scholar 

  46. Bates N. Overdose of insulin and other diabetic medication. Emerg Nurse 2002;10(7):22.

    Google Scholar 

  47. Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 2000;20:2926-2933.

    CAS  Google Scholar 

  48. Kurtz CA, Loebig TG, Anderson DD, DeMeo PJ, Campbell PG. Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med 1999;27(3):363-369.

    CAS  Google Scholar 

  49. Song YH, Godard M, Li Y, Richmond SR, Rosenthal N, Delafontaine P. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J Investig Med 2005;53(3):135-142.

    Article  CAS  Google Scholar 

  50. Waters D, Danska J, Hardy K, et al. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125(11):865- 872.

    CAS  Google Scholar 

  51. Platz EA, Pollak MN, Leitzmann MF, Stampfer MI, Willett WC, Giovannucci E. Plasma insulin-like growth factor-l and binding protein-3 and subsequent risk of prostate cancer in the PSA era. Cancer Causes Control 2005;16(3):255-262.

    Article  Google Scholar 

  52. Jezova D, Komadel L, Mikulaj L. Plasma testosterone response to repeated human chorionic gonadotropin administration is increased in trained athletes. Endocrinol Exp 1987;21(2):143-147.

    CAS  Google Scholar 

  53. Martikainen H, Alen M, Rahkila P, Vihko R. Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes. J Steroid Biochem 1986;25(11):109-112.

    Article  CAS  Google Scholar 

  54. Karila T, Hovatta O, Seppala T. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes. Int J Sports Med 2004;25(4):257-263.

    Article  CAS  Google Scholar 

  55. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003;228(1):1-14.

    CAS  Google Scholar 

  56. Scott J, Phillips GC. Erythropoietin in sports: a new look at an old problem. Curr Sports Med Rep 2005;4(4):224-226.

    Google Scholar 

  57. Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc 2000;32(7):1238-1243.

    Article  CAS  Google Scholar 

  58. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1991;1:88-93.

    Article  Google Scholar 

  59. Sawka MN, Joyner MJ, Miles DS, Robertson RJ, Spriet LL, Young AJ. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid. Med Sci Sports Exerc 1996;28(6):i-viii.

    CAS  Google Scholar 

  60. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am 2005;34(2):271-292, vii.

    Article  CAS  Google Scholar 

  61. Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 2005;34(2):293-313, viii.

    Article  CAS  Google Scholar 

  62. Soetens E, De Meirleir K, Hueting JE. No influence of ACTH on maximal performance. Psychopharmacology 1995; 118(3):260-266.

    Article  CAS  Google Scholar 

  63. Hanberg A. Common disorders of the pituitary gland: hyposecretion versus hypersecretion. J Infus Nurs 2005;28(1):36-44.

    Article  Google Scholar 

  64. World Anti-Doping Agency. The World Anti-Doping Code. The 2005 Prohibited List: International Standard. Available at: http://www.wada-ama.org. Accessed November 4, 2004.

  65. Pringle TD, West RL, Williams SE, Johnson DD. The Role of the Calpain/Calpastatin System in Muscle Hypertrophy Associated with Double-Muscling in Beef. UGA Animal & Dairy Science Annual Report. Gainesville: The University of Florida; 1995:61-65. Available at: http://www.ads.uga.edu/annrpt/1995/95_061.htm. Accessed November 4, 2004.

  66. Grobet L, Martin LJ, Poncelet D, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997;17:71-74.

    Article  CAS  Google Scholar 

  67. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997;94:12457-12461.

    Article  CAS  Google Scholar 

  68. Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350(26):2682-2688.

    Article  CAS  Google Scholar 

  69. The Seattle Times. Muscular 4-year-old may power medical advances. The Associated Press and Baltimore Sun. Available at: http://seattletimes.nwsource.com/text/2001963965_muscleboy24.html. Accessed November 5, 2004.

  70. Aschwanden C. Gene cheats. New Scientist 15 January 2000:24-29.

    Google Scholar 

  71. Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat 1999;194(3):323-324.

    Article  CAS  Google Scholar 

  72. Barton-Davis ER, Shoturma DI, Musaro A, et al. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998;95(26):15603-15607.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Jamie Landis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tim N. Ziegenfuss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. International Society of Sports Nutrition, Deerfield Beach, FL, USA

    Jose Antonio PhD

  2. Division of Nutrition and Endocrinology, Miami Research Associates, Miami, FL, USA

    Douglas Kalman PhD, RD

  3. Department of Health and Exercise Science, University of Oklahoma, Norman, OK, USA

    Jeffrey R. Stout PhD

  4. Department of Health, Human Performance, and Recreation, Baylor University, Waco, TX, USA

    Mike Greenwood PhD  & Darryn S. Willoughby PhD  & 

  5. Division of Exercise Physiology, West Virginia University, Morgantown, WV, USA

    G. Gregory Haff PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press. a part of Spring Science+Business Media, LLC

About this chapter

Cite this chapter

Landis, J., Ziegenfuss, T.N. (2008). Hormonal Supplements Legal and Illegal. In: Antonio, J., Kalman, D., Stout, J.R., Greenwood, M., Willoughby, D.S., Haff, G.G. (eds) Essentials of Sports Nutrition and Supplements. Humana Press. https://doi.org/10.1007/978-1-59745-302-8_23

Download citation

Publish with us

Policies and ethics

Search

Navigation